Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Arcus Biosciences, Inc.”

30 pharma patents match "Arcus Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 30
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 30 pharmaceutical patents matching "Arcus Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

30 results for “Arcus Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 12415854

    Antibodies to TIGIT

    Arcus Biosciences, Inc. · Granted Sep 16, 2025 · Expires Sep 11, 2045

    granted
  2. US 12410170

    2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds

    Arcus Biosciences, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

    granted
  3. US 12384773

    Thiazole compounds and methods of use thereof

    Arcus Biosciences, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  4. US 12310965

    Treatment of cancer utilizing an identified adenosine fingerprint

    Arcus Biosciences, Inc. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  5. US 12281136

    Crystalline forms of a CD73 inhibitor and uses thereof

    Arcus Biosciences, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  6. US 12226425

    Inhibitors of ARG1 and/or ARG2

    Arcus Biosciences, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  7. US 12195447

    Azolopyrimidine for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  8. US 12168023

    Inhibitors of adenosine 5′-nucleotidase

    Arcus Biosciences, Inc. · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  9. US 12103907

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

    Arcus Biosciences, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  10. US 12071411

    Inhibitors of HIF-2α and methods of use thereof

    Arcus Biosciences, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  11. US 12064433

    Pyridone A2R antagonists

    Arcus Biosciences, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  12. US 12054500

    Arginase inhibitors

    Arcus Biosciences, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  13. US 11993584

    Solid forms of an azolopyrimidine compound

    Arcus Biosciences, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  14. US 11970543

    Anti-CD39 antibodies and use thereof

    Arcus Biosciences, Inc. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  15. US 11931343

    CD73 inhibitors

    Arcus Biosciences, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  16. US 11819512

    Solid forms of a CD73 inhibitor and the use thereof

    Arcus Biosciences, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  17. US 11820824

    Antibodies to TIGIT

    Arcus Biosciences, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  18. US 11787762

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

    Arcus Biosciences, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted
  19. US 11667662

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  20. US 11649261

    Crystalline forms of a CD73 inhibitor and uses thereof

    Arcus Biosciences, Inc. · Granted May 16, 2023 · Expires May 11, 2043

    granted
  21. US 11633416

    Oral formulations of CD73 compounds

    Arcus Biosciences, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  22. US 11478479

    Dosing with an azolopyrimidine compound

    Arcus Biosciences, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  23. US 11407712

    Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

    Arcus Biosciences, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  24. US 11267845

    Inhibitors of CD73-mediated immunosuppression

    Arcus Biosciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted